Healthcare Professional (HCP) Survey to Assess the Effectiveness of the Additional Risk Minimization Measures (aRMM) for Casgevy® (exagamglogene autotemcel)

08/08/2025
03/09/2026
EU PAS number:
EUPAS1000000704
Study
Ongoing
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

Vertex HCP Survey (290-102) Protocol Version 3.0_ 01April2025_Redacted.pdf

English (4.2 MB - PDF) View document
Study results
Study report
Other information